BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 24025958)

  • 1. Cost-effectiveness of transcatheter valvular interventions: economic challenges.
    Osnabrugge RL; Kappetein AP; Reynolds MR; Cohen DJ
    EuroIntervention; 2013 Sep; 9 Suppl():S48-54. PubMed ID: 24025958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcatheter aortic valve implantation: the transfemoral access route is the default access.
    Stortecky S; O'Sullivan CJ; Buellesfeld L; Windecker S; Wenaweser P
    EuroIntervention; 2013 Sep; 9 Suppl():S14-8. PubMed ID: 24025952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcatheter aortic valve replacement in nonsurgical candidates with severe, symptomatic aortic stenosis: a cost-effectiveness analysis.
    Simons CT; Cipriano LE; Shah RU; Garber AM; Owens DK; Hlatky MA
    Circ Cardiovasc Qual Outcomes; 2013 Jul; 6(4):419-28. PubMed ID: 23838104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of the Edwards SAPIEN transcatheter heart valve compared with standard management and surgical aortic valve replacement in patients with severe symptomatic aortic stenosis: a Canadian perspective.
    Doble B; Blackhouse G; Goeree R; Xie F
    J Thorac Cardiovasc Surg; 2013 Jul; 146(1):52-60.e3. PubMed ID: 22795437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of transcatheter aortic valve replacement compared with surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results of the PARTNER (Placement of Aortic Transcatheter Valves) trial (Cohort A).
    Reynolds MR; Magnuson EA; Lei Y; Wang K; Vilain K; Li H; Walczak J; Pinto DS; Thourani VH; Svensson LG; Mack MJ; Miller DC; Satler LE; Bavaria J; Smith CR; Leon MB; Cohen DJ;
    J Am Coll Cardiol; 2012 Dec; 60(25):2683-92. PubMed ID: 23122802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cost-effectiveness of transcatheter aortic valve implantation versus surgical aortic valve replacement in patients with severe aortic stenosis at high operative risk.
    Fairbairn TA; Meads DM; Hulme C; Mather AN; Plein S; Blackman DJ; Greenwood JP
    Heart; 2013 Jul; 99(13):914-20. PubMed ID: 23696198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcatheter Aortic Valve Implantation for Treatment of Aortic Valve Stenosis: A Health Technology Assessment.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2016; 16(19):1-94. PubMed ID: 27990197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness considerations in transcatheter management of valvular heart disease.
    Gadey G; Reynolds MR
    Can J Cardiol; 2014 Sep; 30(9):1058-63. PubMed ID: 24999170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic review of the cost-effectiveness of transcatheter aortic valve implantation.
    Indraratna P; Ang SC; Gada H; Yan TD; Manganas C; Bannon P; Cao C
    J Thorac Cardiovasc Surg; 2014 Aug; 148(2):509-14. PubMed ID: 24280719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of transcatheter aortic valve implantation (TAVI) for aortic stenosis in patients who are high risk or contraindicated for surgery: a model-based economic evaluation.
    Orlando R; Pennant M; Rooney S; Khogali S; Bayliss S; Hassan A; Moore D; Barton P
    Health Technol Assess; 2013 Aug; 17(33):1-86. PubMed ID: 23948359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of transcatheter aortic valve replacement compared with standard care among inoperable patients with severe aortic stenosis: results from the placement of aortic transcatheter valves (PARTNER) trial (Cohort B).
    Reynolds MR; Magnuson EA; Wang K; Lei Y; Vilain K; Walczak J; Kodali SK; Lasala JM; O'Neill WW; Davidson CJ; Smith CR; Leon MB; Cohen DJ;
    Circulation; 2012 Mar; 125(9):1102-9. PubMed ID: 22308299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of transcatheter aortic valve replacement in patients ineligible for conventional aortic valve replacement.
    Watt M; Mealing S; Eaton J; Piazza N; Moat N; Brasseur P; Palmer S; Busca R; Sculpher M
    Heart; 2012 Mar; 98(5):370-6. PubMed ID: 22076021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic review of the cost-effectiveness of transcatheter interventions for valvular heart disease.
    Gialama F; Prezerakos P; Apostolopoulos V; Maniadakis N
    Eur Heart J Qual Care Clin Outcomes; 2018 Apr; 4(2):81-90. PubMed ID: 29325012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Costs of transcatheter versus surgical aortic valve replacement in intermediate-risk patients.
    Osnabrugge RL; Head SJ; Genders TS; Van Mieghem NM; De Jaegere PP; van der Boon RM; Kerkvliet JM; Kalesan B; Bogers AJ; Kappetein AP; Hunink MG
    Ann Thorac Surg; 2012 Dec; 94(6):1954-60. PubMed ID: 22959568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Innovative technology-transcatheter aortic valve implantation: cost and reimbursement issues.
    Dahle G; Rein KA; Fiane A; Fosse E; Khushi I; Hagen T; Mishra V
    Scand Cardiovasc J; 2012 Dec; 46(6):345-52. PubMed ID: 22917262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transfemoral transcatheter aortic valve replacement compared with surgical replacement in patients with severe aortic stenosis and comparable risk: cost-utility and its determinants.
    Ribera A; Slof J; Andrea R; Falces C; Gutiérrez E; Del Valle-Fernández R; Morís-de la Tassa C; Mota P; Oteo JF; Cascant P; Altisent OA; Sureda C; Serra V; García-Del Blanco B; Tornos P; Garcia-Dorado D; Ferreira-González I
    Int J Cardiol; 2015 Mar; 182():321-8. PubMed ID: 25585368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcatheter aortic valve implantation 10-year anniversary: review of current evidence and clinical implications.
    Généreux P; Head SJ; Wood DA; Kodali SK; Williams MR; Paradis JM; Spaziano M; Kappetein AP; Webb JG; Cribier A; Leon MB
    Eur Heart J; 2012 Oct; 33(19):2388-98. PubMed ID: 22851654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost effectiveness of transcatheter aortic valve implantation in patients with aortic stenosis in Japan.
    Kodera S; Kiyosue A; Ando J; Komuro I
    J Cardiol; 2018 Mar; 71(3):223-229. PubMed ID: 29153740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Five-year clinical and economic outcomes among patients with medically managed severe aortic stenosis: results from a Medicare claims analysis.
    Clark MA; Arnold SV; Duhay FG; Thompson AK; Keyes MJ; Svensson LG; Bonow RO; Stockwell BT; Cohen DJ
    Circ Cardiovasc Qual Outcomes; 2012 Sep; 5(5):697-704. PubMed ID: 22949492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tools and techniques - statistics: comments on a cost-effectiveness study of TAVI for patients with inoperable aortic stenosis.
    Redekop WK
    EuroIntervention; 2014 Feb; 9(10):1241-3. PubMed ID: 24561740
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.